Neurologic perspectives of Crigler-Najjar syndrome type I

Journal of Child Neurology

Volumn 13, Issue 6, 1998, Pages 265-269

  Shevell, Michael I ^a,c   Majnemer, Annette ^a   Schiff, David ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; COLESTYRAMINE; GLUCURONOSYLTRANSFERASE;

ARTICLE; BRAIN DEVELOPMENT; CASE REPORT; CHILD; CRIGLER NAJJAR SYNDROME; FEMALE; GENE THERAPY; HUMAN; LIVER TRANSPLANTATION; MALE; PHOTOTHERAPY; PRIORITY JOURNAL;

EID: 0031684119     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801300605     Document Type: Article

References (49)

1. Crigler JF, Najjar VA: Congenital familial non-haemolytic jaundice with kernicterus. Pediatrics 1952;10:169-180.
2. Arias IM, Gartner LM, Cohen M, et al: Chronic nonhemolytic unconjugated hyperbilirubinemia with glucoronyl transferase deficiency: Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med 1969;47:395-409.
3. Ritter JK, Yeatman MT, Ferreira P, Owens IS: Identification of a genetic alteration in the code for bilirubin UDP-glucoronyltransferase in the UGT1 gene locus of a Crigler-Najjar Type I patient. J Clin Invest 1992;90:150-155.
4. Lebrune P, Myara A, Hadchouel M, et al: Genetic heterogeneity of Crigler-Najjar syndrome type I: A study of 14 cases. Hum Genet 1994;94:693-697.
5. Blaschke TF, Berk PD, Scharschmidt BF, et al: Crigler-Najjar syndrome-an unusual course with development of neurological disease at age 18 years. Pediatr Res 1974;8:573-590.
6. Odievre M, Trivin F, Eliot N, Alagille D: Case of congenital non-obstructive non-haemolytic jaundice. Arch Dis Child 1978;53: 81-82.
7. Rubaltelli FF, Guerrini P, Reddi E, Jori J: Tin-protoporphyrin in the management of children with Crigler-Najjar disease. Pediatrics 1989;84:728-731.
8. Wolff H, Otto G, Giest G: Liver transplantation in Crigler-Najjar syndrome. A case report. Transplantation 1986;42:84.
9. Whitington PF, Emond JC, Heffron T, Thistlethwaite JR: Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type I. Lancet 1993;342:779-780.
10. Shevell MI, Bernard B, Adelson JW, et al: Crigler-Najjar syndrome type I: treatment by home phototherapy followed by orthotopic hepatic transplantation. J Pediatr 1987;110:429-431.
11. Owens IS: Personal communication, 1993.
12. Childs B, Najjar VA: Familial nonhemolytic jaundice with kernicterus: A report of two cases without neurologic damage. Pediatrics 1956;18:369-377.
13. Childs B, Sidbury JB, Migeon CJ: Glucoronic acid conjugation in patients with familial non-haemolytic jaundice and their relatives. Pediatrics 1959;23:903-913.
14. Blumenschein SD, Kallen RJ, Storey B, et al: Familial non-hemolytic jaundice with late onset of neurological damage. Pediatrics 1968; 42:786-792.
15. Gardner WA, Konigsmark B: Familial nonhemolytic jaundice: Bilirubinosis and encephalopathy. Pediatrics 1969;43:365-376.
16. Rosenthal IM, Zimmerman HJ, Hardy N: Congenital non-hemolytic jaundice with disease of the central nervous system. Pediatrics 1956;18:378-379.
17. Jervis JA: Constitutional non-hemolytic hyperbilirubinemia with findings resembling kernicterus. Arch Neural Psychiatry 1959; 81:55-64.
18. Whittington GL: Congenital non-hemolytic icterus with damage to the central nervous system. Report of a case in a Negro child. Pediatrics 1960;25:437-440.
19. Billing BH, Gray CH, Kulczycka A, et al: Metabolism of C14 bilirubin in congenital nonhemolytic hyperbilirubinemia. Clin Sci 1964; 27:163-170.
20. Aziz AM, Siddiqui AR: Congenital familial non-hemolytic hyperbilirubinemia in an adult with central nervous system derangement. Gastroenterology 1967;52:254-258.
21. Wranne L: Congenital non-hemolytic jaundice. Acta Paediatr Scand 1967;56:552-556.
22. Girotti F, Finocchi G, Sartori L, et al: Congenital non-hemolytic jaundice in a four year old girl without disease of the central nervous system. Helv Paediatr Acta 1969;24:399-403.
23. Jansen FH, Malvaux P, Heirwegh KPM, Devriendt A: Congenital nonhemolytic jaundice: Crigler-Najjar syndrome. Biol Neonate 1969;14:53-57.
24. Huang PWH, Rozdilsky B, Gerrard JW, et al: Crigler-Najjar syndrome in four of five siblings with postmortem findings in one. Arch Pathol 1970;90:536-542.
25. Bloomer JR, Berk PD, Howe RB, Berlin NI: Bilirubin metabolism in congenital non-hemolytic jaundice. Pediatr Res 1971;5:256-264.
26. Wolkoff AW, Chowdhury JR, Gartner LA, et al: Clinical conference. Crigler-Najjar syndrome (type I) in an adult male. Gastroenterology 1979;76:840-848.
27. Yohannan MD, Terry HJ, Littlewood JM: Long term phototherapy in Crigler-Najjar syndrome. Arch Dis Child 1983;58:460-462.
28. Duhamel G, Blanckaert N, Metreau JM, et al: An unusual case of Crigler-Najjar disease in the adult. Classification into types I and II revisited. J Hepatol 1984;1:47-53.
29. Kaufman SS, Wood RP, Shaw BW, et al: Orthotopic liver transplantation for type I Crigler-Najjar syndrome. Hepatology 1986;6: 1259-1262.
30. Pett S, Mowat AP: Crigler-Najjar syndrome types I and II. Clinical experience - King's College Hospital 1972-1978. Phenobarbitone, phototherapy and liver transplantation. Mol Aspects Med 1987; 9:473-482.
31. Moutos D, Morris M, Marks W, et al: Late onset neurologic deterioration in congenital non-hemolytic jaundice: Treatment with charcoal hemoperfusion. Pediatr Res 1988;23:309A.
32. Ahmed P, Pratt A, Land VJ, et al: Multiple plasma exchanges successfully maintain a young adult patient with Crigler-Najjar syndrome type I. J Clin Apheresis 1989;5:17-20.
33. Solomon G, Labar D, Galbraith RA, et al: Neurophysiological abnormalities in adolescents with type I Crigler-Najjar syndrome. Electroencephalogr Clin Neurophysiol 1990;76:473-475.
34. Nazer H, Gunasekaran TS, Sakati NA, Nyhan WL: Concurrence of Robinow syndrome and Crigler-Najjar syndrome in two offspring of first cousins. Am J Med Genet 1990;37:516-518.
35. Taylor WG, Walkinshaw SA, Farquharson RG, et al: Pregnancy in Crigler-Najjar syndrome. Case report. Br J Obstet Gynaecol 1991; 98:1290-1291.
36. Galbraith RA, Drummond GS, Kappas A: Suppression of bilirubin production in the Crigler-Najjar type I syndrome: Studies with heme oxygenase inhibitor tin-mesoporphyrin. Pediatrics 1992;89: 175-182.
37. Labrune PH, Myara A, Francoual J, et al: Cerebellar symptoms as the presenting manifestations of bilirubin encephalopathy in children with Crigler-Najjar syndrome type I. Pediatrics 1992;89: 768-770.
38. Hughes-Benzie R, Uttley DA, Heick HM: Crigler-Najjar syndrome type I: Management with phototherapy crib mattress, letter. Arch Dis Child 1993;69:470.
39. Rubaltelli FF, Dario C, Zancan L: Congenital nonobstructive nonhemolytic jaundice; effect of tin-mesoporphyrin. Pediatrics 1995; 95:942-944.
40. Sokal EM, Silva ES, Hermans D, et al: Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Transplantation 1995;60:1095-1098.
41. Connolly AM, Volpe JJ: Clinical features of bilirubin encephalopathy. Clin Perinatal 1990;17:371-379.
42. Turkel SB: Autopsy findings associated with neonatal hyperbilirubinemia. Clin Perinatol 1990;17:381-396.
43. Schmorl G: Zur Kenntnis des icterus neonatorum. Verh Dtsch Ges Pathol 1903;6:109.
44. Newman TB, Maisels MJ: Does hyperbilirubinemia damage the brain of healthy full-term infants? Clin Perinatol 1990;17:331-358.
45. 35S]-methionine incorporation, and mitochondrial function. Pediatr Res 1989;25:364-368.
46. Amit Y, Poznansky MJ, Schiff D: Bilirubin toxicity in a neuroblastoma cell line N-115: II. Delayed effects and recovery. Pediatr Res 1989;25:369-372.
47. Hansen THR: Bilirubin in the brain. Distribution and effects on neurophysiological and neurochemical processes. Clin Pediatr 1994;452-459.
48. Hansen THR: More to be learned from Crigler-Najjar patients, letter. Pediatrics 1992;89:1268-1269.
49. Brierley CH, Burchell B: Human UDP-glucoronyl transferases: Chemical defense, jaundice and gene therapy. Bioessays 1993;15:749-754.